Home / Stocks / GRCE

GRCE insider trading

Grace Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
11
Bought · 24 mo
$806k
Buys · last 90 days
11 · $806k
Most recent buy
2026-10-26

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-10-26Opaleye Management Inc.
10% owner
Bought87,801$1.81$159k
2026-10-21Opaleye Management Inc.
10% owner
Bought4,256$1.88$8k
2026-10-16Opaleye Management Inc.
10% owner
Bought71,065$1.92$136k
2026-10-13Opaleye Management Inc.
10% owner
Bought14,632$2.03$30k
2026-10-05Opaleye Management Inc.
10% owner
Bought60,490$2.05$124k
2026-10-01Opaleye Management Inc.
10% owner
Bought15,089$2.10$32k
2026-10-01Opaleye Management Inc.
10% owner
Bought7,849$2.09$16k
2026-09-23Opaleye Management Inc.
10% owner
Bought15,089$2.10$32k
2026-09-10Opaleye Management Inc.
10% owner
Bought15,229$2.09$32k
2026-09-10Kohli Prashant
Chief Executive Officer
Bought100,000$2.14$214k
2026-08-19Opaleye Management Inc.
10% owner
Bought11,608$2.09$24k

Most active insider buyers

InsiderRoleBuysTotal bought
Opaleye Management Inc.10% owner10$592k
Kohli PrashantChief Executive Officer1$214k

See GRCE on the chart

Every insider buy and sell for GRCE plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.